Follow
Sharareh Eskandari
Title
Cited by
Cited by
Year
Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering
S Eskandari, T Guerin, I Toth, RJ Stephenson
Advanced drug delivery reviews 110, 169-187, 2017
3232017
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model
S Eskandari, J Varshosaz, M Minaiyan, M Tabbakhian
International journal of nanomedicine, 363-371, 2011
1322011
Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants
J Varshosaz, S Eskandari, M Tabbakhian
Carbohydrate polymers 88 (4), 1157-1163, 2012
1192012
Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design
J Varshosaz, S Eskandari, M Tabakhian
Pharmaceutical development and technology 15 (1), 89-96, 2010
952010
Structure–activity relationship of lipid core peptide-based Group A Streptococcus vaccine candidates
A Chan, WM Hussein, KA Ghaffar, N Marasini, A Mostafa, S Eskandari, ...
Bioorganic & medicinal chemistry 24 (14), 3095-3101, 2016
262016
Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosis
HA Al-Nazal, E Cooper, MF Ho, S Eskandari, V Majam, AK Giddam, ...
Cell Host & Microbe 29 (6), 894-903. e5, 2021
172021
Prime-pull immunization with a bivalent M-protein and spy-CEP peptide vaccine adjuvanted with CAF® 01 liposomes induces both mucosal and peripheral protection from covR/S …
V Ozberk, S Reynolds, Y Huo, A Calcutt, S Eskandari, J Dooley, JL Mills, ...
Mbio 12 (1), 10.1128/mbio. 03537-20, 2021
172021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
M Pandey, V Ozberk, S Eskandari, AO Shalash, MA Joyce, HA Saffran, ...
Clinical & Translational Immunology 10 (3), e1260, 2021
152021
Synthesis of mannosylated lipopeptides with receptor targeting properties
B Sedaghat, RJ Stephenson, AK Giddam, S Eskandari, SH Apte, ...
Bioconjugate Chemistry 27 (3), 533-548, 2016
152016
Systematic evaluation of self-adjuvanting lipopeptide nano-vaccine platforms for the induction of potent CD8+ T-cell responses
SH Apte, RJ Stephenson, P Simerska, PL Groves, S Aljohani, S Eskandari, ...
Nanomedicine 11 (2), 137-152, 2016
132016
Synthesis and Characterisation of Self‐Assembled and Self‐Adjuvanting Asymmetric Multi‐Epitope Lipopeptides of Ovalbumin
S Eskandari, RJ Stephenson, AA Fuaad, SH Apte, DL Doolan, I Toth
Chemistry–A European Journal 21 (3), 1251-1261, 2015
132015
Formulation and in-vitro characterization of extended release pellets of indomethacin using powder-layering technique
S Eskandari, J Varshosaz, G Akhavanfarid, G Hafizi
Research in Pharmaceutical Sciences 2 (2), 67-75, 2009
122009
Influence of physicochemical properties of lipopeptide adjuvants on the immune response: a rationale for engineering a potent vaccine
S Eskandari, DJ Pattinson, RJ Stephenson, PL Groves, SH Apte, ...
Chemistry–A European Journal 24 (39), 9892-9902, 2018
92018
Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery
S Eskandari, P Varamini, I Toth
Journal of Liposome Research 23 (4), 311-317, 2013
92013
Factors affecting the production of nanostructure lipid carriers of valproic acid
J Varshosaz, S Eskandari, R Kennedy, M Tabbakhian, M Minaiyan
Journal of biomedical nanotechnology 9 (2), 202-212, 2013
92013
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers
S Eskandari, J Varshosaz, M Minaiyan, M Tabbakhian
vivo, 0
9
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
V Ozberk, M Zaman, A Lepletier, S Eskandari, J Kaden, JL Mills, A Calcutt, ...
Nature Communications 14 (1), 5963, 2023
32023
Current boundaries in the formulation of lipid based delivery systems
S Eskandari, R Stephenson, I Toth
Liposomal delivery systems: advances and challenges. London: Future Science Ltd, 2016
22016
Peptide-Protein Conjugation and Characterization to Develop Vaccines for Group A Streptococcus
S Eskandari, MF Good, M Pandey
Peptide Conjugation: Methods and Protocols, 17-33, 2021
12021
Arthritis and Transdermal Glucosamine (Rahamin®): A brief introduction
S Eskandari
Iranian Journal of Rheumatology 1 (1), 0-0, 2012
12012
The system can't perform the operation now. Try again later.
Articles 1–20